iBio (IBIO) Operating Expenses (2010 - 2026)
iBio (IBIO) posted quarterly Operating Expenses of $8.4 million for Q1 2026, up 71.45% year-over-year from $4.9 million in Q1 2025, and down 11.43% quarter-over-quarter from $9.4 million in Q4 2025.
iBio (IBIO) Operating Expenses (2010 - 2026) Analysis & Trends
iBio (IBIO) has reported Operating Expenses for 17 consecutive years, with $8.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 71.45% year-over-year to $8.4 million; the TTM figure through Mar 2026 stood at $29.3 million (up 70.23% YoY), while the FY2025 annual figure was $19.0 million, up 12.71% from the prior year.
- Operating Expenses declined to $8.4 million in Q1 2026 per IBIO's latest filing, from $9.4 million in the prior quarter.
- Across five years, Operating Expenses topped out at $10.6 million in Q4 2022 and bottomed at $3.6 million in Q2 2024.
- Historically, Operating Expenses has averaged $6.4 million across 5 years, with a median of $5.4 million in 2025.
- Annual changes were most pronounced in 2023 — Operating Expenses plunged 57.48% — and 2025, when it surged 104.48%.
- iBio's Operating Expenses stood at $10.6 million in 2022, then plunged by 57.48% to $4.5 million in 2023, then increased by 2.74% to $4.6 million in 2024, then soared by 104.48% to $9.4 million in 2025, then decreased by 11.43% to $8.4 million in 2026.
- Business Quant data shows IBIO's Operating Expenses at $8.4 million in Q1 2026, $9.4 million in Q4 2025, and $6.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | iBio | 175.21 Mn | 175.21 Mn | - | 8.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.37 Mn |
| Dec 31, 2025 | 9.45 Mn |
| Sep 30, 2025 | 6.05 Mn |
| Jun 30, 2025 | 5.40 Mn |
| Mar 31, 2025 | 4.88 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Sep 30, 2024 | 4.11 Mn |
| Jun 30, 2024 | 3.58 Mn |
| Mar 31, 2024 | 3.63 Mn |
| Dec 31, 2023 | 4.50 Mn |
| Sep 30, 2023 | 5.15 Mn |
| Jun 30, 2023 | 4.97 Mn |
| Mar 31, 2023 | 6.17 Mn |
| Dec 31, 2022 | 10.57 Mn |
| Sep 30, 2022 | 7.64 Mn |
| Jun 30, 2022 | 10.45 Mn |
| Mar 31, 2022 | 8.59 Mn |
| Dec 31, 2021 | 7.23 Mn |
| Sep 30, 2021 | 5.31 Mn |
| Jun 30, 2021 | 9.74 Mn |